Introduction
Hemorrhage is a common complication in patients undergoing anticoagulant therapy when it is halted to screen a patient's coagulation system; also, the frequency of bleeding resulting from anticoagulant therapy increases with long-term usage (1) . In relation to this issue, bleeding may occur in different anatomic regions, such as intra-cranial, intra-spinal, intra-thoracic, intra-abdominal, intra-joint, epistaxis, urinary, and gastrointestinal regions (1) (2) (3) (4) . Life-threatening intra-cranial and spinal hemorrhages are the most serious complications of oral anticoagulant therapy. A couple of articles in the literature have reported that a spinal hemorrhage that might have evolved secondary to anticoagulant therapy, may be seen in epidural, subdural, subarachnoid, and intra-spinal cases in the absence of abnormalities of coagulation, blood dyscrasias, lumber puncture or trauma, neoplasm, and arterio-venous malformation (5-7). Although intra-cranial hemorrhage along with spinal epidural hematoma can occur often, spinal subdural hematoma rarely occurs (2-6). The occurrence of spinal subdural hematoma along with intra-cranial subarachnoid hemorrhage (SAH) is extremely rare. Herein, we discuss the case of an elderly female who had concomitant spinal subdural hematoma and cranial SAH associated with warfarin therapy.
oriented and was able to answer questions appropriately. Her pupils were equal, round, and reactive to light, with intact extra ocular movements. Her heart beats were irregular without any murmur, rub, or gallop, and her rectal tone was normal. Examination of her motor strength in both lower extremities revealed a power of 2-5. Her deep tendon reflexes were also absent on both lower extremities. Her prothrombin time (PT) was prolonged tolerably and her international normalized ratio (INR) level was immeasurably high. The patient's other initial laboratory findings are shown in Table 1 . In addition to these findings, because of a suspected spinal hemorrhage, magnetic resonance imaging (MRI) of the thoraco-lumbar spine was performed. The MRI scan of this region showed evidence of a massive subdural hemorrhagic collection (hematoma). The subdural hematoma is shown in Figure A medical remedy were sought. The neurosurgeon did not consider an operation for the patient because the time of the hemorrhage onset and clinical nature of the patient's symptoms. Therefore, the patient was hospitalized in the neurosurgery ward. The patient was managed with a conservative treatment in the neurosurgical unit; however, the patient's neurological findings did not improve. Unfortunately, the patient died on the 21st day after admission to the ED. The patient's informed consent was obtained before preparation of this report.
Discussion
Spinal hematomas may occur as a complication of hemorrhagic diathesis, thrombocytopenia, invasive spinal surgery, traumas, spinal anesthesia, thrombotic disorders, thrombocytopenia, or lumbar puncture; hemorrhage might also be developed in patients after receiving warfarin therapy only (6) (7) (8) . Warfarin may be used to preserve anticoagulation for prophylaxis or for the treatment of thrombosis, which has been reported in patients with atrial fibrillation, valvular heart disease, mechanical heart valves, deep vein thrombosis, pulmonary emboli, and acute ischemic stroke (9) . However, there is a powerful relationship between the intensity of anticoagulant treatment and the risk of bleeding. The intensity of the anticoagulant effect is most likely to be an important risk factor for intra-cranial hemorrhage, independent of the indication for therapy, with the risk increasing dramatically with an INR of >4.0-5.0. The risk of intracerebral hemorrhage, the most feared and the most deadly complication of oral anticoagulant therapy, e.g., with warfarin sodium (Coumadin®, Zentiva, İstanbul, Turkey), is doubled with the increase of approximately each unit in the INR, as reported by Goldstein and Greenberg (10) . Therefore, patients receiving anticoagulant therapy should be monitored in clinics for therapeutic INR optimization (targeted INR<2.0) in consideration of the bleeding risks. At the same time, the bleeding risk for intra-cranial hemorrhage may be high among older patients, in particular those aged >75 years, when the INR is above therapeutic levels (11).
Some comorbid diseases have been associated with bleeding during warfarin therapy; these diseases include treated hypertension, cerebrovascular disease, ischemic stroke, malignancy, heart failure, and renal insufficiency (9) (10) (11) . In our reported case, even after the clinical examination on the initial presentation, our patient continued to receive a drug for hypertension and diabetes mellitus, and furthermore the patient was taking warfarin therapy because of atrial fibrillation. Also, she was an older patient and she also had an abnormal coagulation profile (highly elevated PT and immeasurably high INR). On the basis of the patient's characteristics, the intensity of the anticoagulant effect and comorbid diseases, it seems most likely that an intraspinal hematoma and intra-cranial hemorrhage in a patient on anticoagulant therapy will occur. In addition to this, bleeding might result from other body parts in the context of coagulation abnormalities as well. Decompression of the spinal cord via neurosurgical evacuation of the hematoma is one option in the current management of these patients with spinal cord compression associated with neurological deficits. But on the other hand, the general medical condition of the patient and the worsening of the cranial pathology should be considered when making a decision about surgical treatment.
In conclusion, spinal subdural hematoma and intra-cranial SAH are known to be neurological emergencies. A patient's coagulation profile should be screened in the context of anticoagulant therapy in appropriate or short time periods, as an early clinical intervention will result in a greater likelihood of the patient's recovery.
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